Global Antidepressants Market Growth 2025-2031

October 2025 | 89 pages | ID: G96FFA3D290EN
LP Information

Abstracts

The global Antidepressants market size is predicted to grow from US$ 15440 million in 2025 to US$ 18900 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the ?Antidepressants Industry Forecast? looks at past sales and reviews total world Antidepressants sales in 2024, providing a comprehensive analysis by region and market sector of projected Antidepressants sales for 2025 through 2031. With Antidepressants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antidepressants industry.

This Insight Report provides a comprehensive analysis of the global Antidepressants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antidepressants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antidepressants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antidepressants and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antidepressants.

This report presents a comprehensive overview, market shares, and growth opportunities of Antidepressants market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tricyclic Antidepressants
• Selective Serotonin Reuptake Inhibitors
• Selective Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Benzodiazepines
• Antipsychotics
• Novel Agents

Segmentation by Application:

• Hospitals
• Clinics
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• H Lundbeck
• Astrazeneca
• Eli Lilly and Company
• Sun Pharmaceuticals
• Pfizer Inc.
• GlaxoSmithKline
• Bristol-Myers Squibb Company
• Johnson & Johnson
• Merck
• Sanofi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antidepressants market?
What factors are driving Antidepressants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antidepressants market opportunities vary by end market size?
How does Antidepressants break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antidepressants Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Antidepressants by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Antidepressants by Country/Region, 2020, 2024 & 2031
2.2 Antidepressants Segment by Type
  2.2.1 Tricyclic Antidepressants
  2.2.2 Selective Serotonin Reuptake Inhibitors
  2.2.3 Selective Norepinephrine Reuptake Inhibitors
  2.2.4 Monoamine Oxidase Inhibitors
  2.2.5 Benzodiazepines
  2.2.6 Antipsychotics
  2.2.7 Novel Agents
2.3 Antidepressants Sales by Type
  2.3.1 Global Antidepressants Sales Market Share by Type (2020-2025)
  2.3.2 Global Antidepressants Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Antidepressants Sale Price by Type (2020-2025)
2.4 Antidepressants Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Other
2.5 Antidepressants Sales by Application
  2.5.1 Global Antidepressants Sale Market Share by Application (2020-2025)
  2.5.2 Global Antidepressants Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Antidepressants Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Antidepressants Breakdown Data by Company
  3.1.1 Global Antidepressants Annual Sales by Company (2020-2025)
  3.1.2 Global Antidepressants Sales Market Share by Company (2020-2025)
3.2 Global Antidepressants Annual Revenue by Company (2020-2025)
  3.2.1 Global Antidepressants Revenue by Company (2020-2025)
  3.2.2 Global Antidepressants Revenue Market Share by Company (2020-2025)
3.3 Global Antidepressants Sale Price by Company
3.4 Key Manufacturers Antidepressants Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Antidepressants Product Location Distribution
  3.4.2 Players Antidepressants Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ANTIDEPRESSANTS BY GEOGRAPHIC REGION

4.1 World Historic Antidepressants Market Size by Geographic Region (2020-2025)
  4.1.1 Global Antidepressants Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Antidepressants Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antidepressants Market Size by Country/Region (2020-2025)
  4.2.1 Global Antidepressants Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Antidepressants Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antidepressants Sales Growth
4.4 APAC Antidepressants Sales Growth
4.5 Europe Antidepressants Sales Growth
4.6 Middle East & Africa Antidepressants Sales Growth

5 AMERICAS

5.1 Americas Antidepressants Sales by Country
  5.1.1 Americas Antidepressants Sales by Country (2020-2025)
  5.1.2 Americas Antidepressants Revenue by Country (2020-2025)
5.2 Americas Antidepressants Sales by Type (2020-2025)
5.3 Americas Antidepressants Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antidepressants Sales by Region
  6.1.1 APAC Antidepressants Sales by Region (2020-2025)
  6.1.2 APAC Antidepressants Revenue by Region (2020-2025)
6.2 APAC Antidepressants Sales by Type (2020-2025)
6.3 APAC Antidepressants Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Antidepressants by Country
  7.1.1 Europe Antidepressants Sales by Country (2020-2025)
  7.1.2 Europe Antidepressants Revenue by Country (2020-2025)
7.2 Europe Antidepressants Sales by Type (2020-2025)
7.3 Europe Antidepressants Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antidepressants by Country
  8.1.1 Middle East & Africa Antidepressants Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Antidepressants Revenue by Country (2020-2025)
8.2 Middle East & Africa Antidepressants Sales by Type (2020-2025)
8.3 Middle East & Africa Antidepressants Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antidepressants
10.3 Manufacturing Process Analysis of Antidepressants
10.4 Industry Chain Structure of Antidepressants

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Antidepressants Distributors
11.3 Antidepressants Customer

12 WORLD FORECAST REVIEW FOR ANTIDEPRESSANTS BY GEOGRAPHIC REGION

12.1 Global Antidepressants Market Size Forecast by Region
  12.1.1 Global Antidepressants Forecast by Region (2026-2031)
  12.1.2 Global Antidepressants Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antidepressants Forecast by Type (2026-2031)
12.7 Global Antidepressants Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 H Lundbeck
  13.1.1 H Lundbeck Company Information
  13.1.2 H Lundbeck Antidepressants Product Portfolios and Specifications
  13.1.3 H Lundbeck Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 H Lundbeck Main Business Overview
  13.1.5 H Lundbeck Latest Developments
13.2 Astrazeneca
  13.2.1 Astrazeneca Company Information
  13.2.2 Astrazeneca Antidepressants Product Portfolios and Specifications
  13.2.3 Astrazeneca Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Astrazeneca Main Business Overview
  13.2.5 Astrazeneca Latest Developments
13.3 Eli Lilly and Company
  13.3.1 Eli Lilly and Company Company Information
  13.3.2 Eli Lilly and Company Antidepressants Product Portfolios and Specifications
  13.3.3 Eli Lilly and Company Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Eli Lilly and Company Main Business Overview
  13.3.5 Eli Lilly and Company Latest Developments
13.4 Sun Pharmaceuticals
  13.4.1 Sun Pharmaceuticals Company Information
  13.4.2 Sun Pharmaceuticals Antidepressants Product Portfolios and Specifications
  13.4.3 Sun Pharmaceuticals Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Sun Pharmaceuticals Main Business Overview
  13.4.5 Sun Pharmaceuticals Latest Developments
13.5 Pfizer Inc.
  13.5.1 Pfizer Inc. Company Information
  13.5.2 Pfizer Inc. Antidepressants Product Portfolios and Specifications
  13.5.3 Pfizer Inc. Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Pfizer Inc. Main Business Overview
  13.5.5 Pfizer Inc. Latest Developments
13.6 GlaxoSmithKline
  13.6.1 GlaxoSmithKline Company Information
  13.6.2 GlaxoSmithKline Antidepressants Product Portfolios and Specifications
  13.6.3 GlaxoSmithKline Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 GlaxoSmithKline Main Business Overview
  13.6.5 GlaxoSmithKline Latest Developments
13.7 Bristol-Myers Squibb Company
  13.7.1 Bristol-Myers Squibb Company Company Information
  13.7.2 Bristol-Myers Squibb Company Antidepressants Product Portfolios and Specifications
  13.7.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Bristol-Myers Squibb Company Main Business Overview
  13.7.5 Bristol-Myers Squibb Company Latest Developments
13.8 Johnson & Johnson
  13.8.1 Johnson & Johnson Company Information
  13.8.2 Johnson & Johnson Antidepressants Product Portfolios and Specifications
  13.8.3 Johnson & Johnson Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Johnson & Johnson Main Business Overview
  13.8.5 Johnson & Johnson Latest Developments
13.9 Merck
  13.9.1 Merck Company Information
  13.9.2 Merck Antidepressants Product Portfolios and Specifications
  13.9.3 Merck Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Merck Main Business Overview
  13.9.5 Merck Latest Developments
13.10 Sanofi
  13.10.1 Sanofi Company Information
  13.10.2 Sanofi Antidepressants Product Portfolios and Specifications
  13.10.3 Sanofi Antidepressants Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Sanofi Main Business Overview
  13.10.5 Sanofi Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antidepressants Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antidepressants Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Tricyclic Antidepressants
Table 4. Major Players of Selective Serotonin Reuptake Inhibitors
Table 5. Major Players of Selective Norepinephrine Reuptake Inhibitors
Table 6. Major Players of Monoamine Oxidase Inhibitors
Table 7. Major Players of Benzodiazepines
Table 8. Major Players of Antipsychotics
Table 9. Major Players of Novel Agents
Table 10. Global Antidepressants Sales by Type (2020-2025) & (K Units)
Table 11. Global Antidepressants Sales Market Share by Type (2020-2025)
Table 12. Global Antidepressants Revenue by Type (2020-2025) & ($ million)
Table 13. Global Antidepressants Revenue Market Share by Type (2020-2025)
Table 14. Global Antidepressants Sale Price by Type (2020-2025) & (USD/Unit)
Table 15. Global Antidepressants Sale by Application (2020-2025) & (K Units)
Table 16. Global Antidepressants Sale Market Share by Application (2020-2025)
Table 17. Global Antidepressants Revenue by Application (2020-2025) & ($ million)
Table 18. Global Antidepressants Revenue Market Share by Application (2020-2025)
Table 19. Global Antidepressants Sale Price by Application (2020-2025) & (USD/Unit)
Table 20. Global Antidepressants Sales by Company (2020-2025) & (K Units)
Table 21. Global Antidepressants Sales Market Share by Company (2020-2025)
Table 22. Global Antidepressants Revenue by Company (2020-2025) & ($ millions)
Table 23. Global Antidepressants Revenue Market Share by Company (2020-2025)
Table 24. Global Antidepressants Sale Price by Company (2020-2025) & (USD/Unit)
Table 25. Key Manufacturers Antidepressants Producing Area Distribution and Sales Area
Table 26. Players Antidepressants Products Offered
Table 27. Antidepressants Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 28. New Products and Potential Entrants
Table 29. Market M&A Activity & Strategy
Table 30. Global Antidepressants Sales by Geographic Region (2020-2025) & (K Units)
Table 31. Global Antidepressants Sales Market Share Geographic Region (2020-2025)
Table 32. Global Antidepressants Revenue by Geographic Region (2020-2025) & ($ millions)
Table 33. Global Antidepressants Revenue Market Share by Geographic Region (2020-2025)
Table 34. Global Antidepressants Sales by Country/Region (2020-2025) & (K Units)
Table 35. Global Antidepressants Sales Market Share by Country/Region (2020-2025)
Table 36. Global Antidepressants Revenue by Country/Region (2020-2025) & ($ millions)
Table 37. Global Antidepressants Revenue Market Share by Country/Region (2020-2025)
Table 38. Americas Antidepressants Sales by Country (2020-2025) & (K Units)
Table 39. Americas Antidepressants Sales Market Share by Country (2020-2025)
Table 40. Americas Antidepressants Revenue by Country (2020-2025) & ($ millions)
Table 41. Americas Antidepressants Sales by Type (2020-2025) & (K Units)
Table 42. Americas Antidepressants Sales by Application (2020-2025) & (K Units)
Table 43. APAC Antidepressants Sales by Region (2020-2025) & (K Units)
Table 44. APAC Antidepressants Sales Market Share by Region (2020-2025)
Table 45. APAC Antidepressants Revenue by Region (2020-2025) & ($ millions)
Table 46. APAC Antidepressants Sales by Type (2020-2025) & (K Units)
Table 47. APAC Antidepressants Sales by Application (2020-2025) & (K Units)
Table 48. Europe Antidepressants Sales by Country (2020-2025) & (K Units)
Table 49. Europe Antidepressants Revenue by Country (2020-2025) & ($ millions)
Table 50. Europe Antidepressants Sales by Type (2020-2025) & (K Units)
Table 51. Europe Antidepressants Sales by Application (2020-2025) & (K Units)
Table 52. Middle East & Africa Antidepressants Sales by Country (2020-2025) & (K Units)
Table 53. Middle East & Africa Antidepressants Revenue Market Share by Country (2020-2025)
Table 54. Middle East & Africa Antidepressants Sales by Type (2020-2025) & (K Units)
Table 55. Middle East & Africa Antidepressants Sales by Application (2020-2025) & (K Units)
Table 56. Key Market Drivers & Growth Opportunities of Antidepressants
Table 57. Key Market Challenges & Risks of Antidepressants
Table 58. Key Industry Trends of Antidepressants
Table 59. Antidepressants Raw Material
Table 60. Key Suppliers of Raw Materials
Table 61. Antidepressants Distributors List
Table 62. Antidepressants Customer List
Table 63. Global Antidepressants Sales Forecast by Region (2026-2031) & (K Units)
Table 64. Global Antidepressants Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Americas Antidepressants Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Americas Antidepressants Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. APAC Antidepressants Sales Forecast by Region (2026-2031) & (K Units)
Table 68. APAC Antidepressants Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 69. Europe Antidepressants Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Europe Antidepressants Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Middle East & Africa Antidepressants Sales Forecast by Country (2026-2031) & (K Units)
Table 72. Middle East & Africa Antidepressants Revenue Forecast by Country (2026-2031) & ($ millions)
Table 73. Global Antidepressants Sales Forecast by Type (2026-2031) & (K Units)
Table 74. Global Antidepressants Revenue Forecast by Type (2026-2031) & ($ millions)
Table 75. Global Antidepressants Sales Forecast by Application (2026-2031) & (K Units)
Table 76. Global Antidepressants Revenue Forecast by Application (2026-2031) & ($ millions)
Table 77. H Lundbeck Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 78. H Lundbeck Antidepressants Product Portfolios and Specifications
Table 79. H Lundbeck Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. H Lundbeck Main Business
Table 81. H Lundbeck Latest Developments
Table 82. Astrazeneca Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 83. Astrazeneca Antidepressants Product Portfolios and Specifications
Table 84. Astrazeneca Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Astrazeneca Main Business
Table 86. Astrazeneca Latest Developments
Table 87. Eli Lilly and Company Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 88. Eli Lilly and Company Antidepressants Product Portfolios and Specifications
Table 89. Eli Lilly and Company Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Eli Lilly and Company Main Business
Table 91. Eli Lilly and Company Latest Developments
Table 92. Sun Pharmaceuticals Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 93. Sun Pharmaceuticals Antidepressants Product Portfolios and Specifications
Table 94. Sun Pharmaceuticals Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Sun Pharmaceuticals Main Business
Table 96. Sun Pharmaceuticals Latest Developments
Table 97. Pfizer Inc. Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Inc. Antidepressants Product Portfolios and Specifications
Table 99. Pfizer Inc. Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Pfizer Inc. Main Business
Table 101. Pfizer Inc. Latest Developments
Table 102. GlaxoSmithKline Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 103. GlaxoSmithKline Antidepressants Product Portfolios and Specifications
Table 104. GlaxoSmithKline Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. GlaxoSmithKline Main Business
Table 106. GlaxoSmithKline Latest Developments
Table 107. Bristol-Myers Squibb Company Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 108. Bristol-Myers Squibb Company Antidepressants Product Portfolios and Specifications
Table 109. Bristol-Myers Squibb Company Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bristol-Myers Squibb Company Main Business
Table 111. Bristol-Myers Squibb Company Latest Developments
Table 112. Johnson & Johnson Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 113. Johnson & Johnson Antidepressants Product Portfolios and Specifications
Table 114. Johnson & Johnson Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Johnson & Johnson Main Business
Table 116. Johnson & Johnson Latest Developments
Table 117. Merck Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck Antidepressants Product Portfolios and Specifications
Table 119. Merck Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Merck Main Business
Table 121. Merck Latest Developments
Table 122. Sanofi Basic Information, Antidepressants Manufacturing Base, Sales Area and Its Competitors
Table 123. Sanofi Antidepressants Product Portfolios and Specifications
Table 124. Sanofi Antidepressants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Sanofi Main Business
Table 126. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Antidepressants
Figure 2. Antidepressants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antidepressants Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Antidepressants Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antidepressants Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antidepressants Sales Market Share by Country/Region (2024)
Figure 10. Antidepressants Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Tricyclic Antidepressants
Figure 12. Product Picture of Selective Serotonin Reuptake Inhibitors
Figure 13. Product Picture of Selective Norepinephrine Reuptake Inhibitors
Figure 14. Product Picture of Monoamine Oxidase Inhibitors
Figure 15. Product Picture of Benzodiazepines
Figure 16. Product Picture of Antipsychotics
Figure 17. Product Picture of Novel Agents
Figure 18. Global Antidepressants Sales Market Share by Type in 2025
Figure 19. Global Antidepressants Revenue Market Share by Type (2020-2025)
Figure 20. Antidepressants Consumed in Hospitals
Figure 21. Global Antidepressants Market: Hospitals (2020-2025) & (K Units)
Figure 22. Antidepressants Consumed in Clinics
Figure 23. Global Antidepressants Market: Clinics (2020-2025) & (K Units)
Figure 24. Antidepressants Consumed in Other
Figure 25. Global Antidepressants Market: Other (2020-2025) & (K Units)
Figure 26. Global Antidepressants Sale Market Share by Application (2024)
Figure 27. Global Antidepressants Revenue Market Share by Application in 2025
Figure 28. Antidepressants Sales by Company in 2025 (K Units)
Figure 29. Global Antidepressants Sales Market Share by Company in 2025
Figure 30. Antidepressants Revenue by Company in 2025 ($ millions)
Figure 31. Global Antidepressants Revenue Market Share by Company in 2025
Figure 32. Global Antidepressants Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Antidepressants Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Antidepressants Sales 2020-2025 (K Units)
Figure 35. Americas Antidepressants Revenue 2020-2025 ($ millions)
Figure 36. APAC Antidepressants Sales 2020-2025 (K Units)
Figure 37. APAC Antidepressants Revenue 2020-2025 ($ millions)
Figure 38. Europe Antidepressants Sales 2020-2025 (K Units)
Figure 39. Europe Antidepressants Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Antidepressants Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Antidepressants Revenue 2020-2025 ($ millions)
Figure 42. Americas Antidepressants Sales Market Share by Country in 2025
Figure 43. Americas Antidepressants Revenue Market Share by Country (2020-2025)
Figure 44. Americas Antidepressants Sales Market Share by Type (2020-2025)
Figure 45. Americas Antidepressants Sales Market Share by Application (2020-2025)
Figure 46. United States Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Antidepressants Sales Market Share by Region in 2025
Figure 51. APAC Antidepressants Revenue Market Share by Region (2020-2025)
Figure 52. APAC Antidepressants Sales Market Share by Type (2020-2025)
Figure 53. APAC Antidepressants Sales Market Share by Application (2020-2025)
Figure 54. China Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 58. India Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Antidepressants Sales Market Share by Country in 2025
Figure 62. Europe Antidepressants Revenue Market Share by Country (2020-2025)
Figure 63. Europe Antidepressants Sales Market Share by Type (2020-2025)
Figure 64. Europe Antidepressants Sales Market Share by Application (2020-2025)
Figure 65. Germany Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 66. France Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Antidepressants Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Antidepressants Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Antidepressants Sales Market Share by Application (2020-2025)
Figure 73. Egypt Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Antidepressants Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Antidepressants in 2025
Figure 79. Manufacturing Process Analysis of Antidepressants
Figure 80. Industry Chain Structure of Antidepressants
Figure 81. Channels of Distribution
Figure 82. Global Antidepressants Sales Market Forecast by Region (2026-2031)
Figure 83. Global Antidepressants Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Antidepressants Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Antidepressants Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Antidepressants Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Antidepressants Revenue Market Share Forecast by Application (2026-2031)